1. Tang DH, Harrington AR, Lee JK, Armstrong EP. A systematic review of economic studies on biologic agents used to treat Crohn’s disease. Inflammatory Bowel Diseases 2013;19:2673-94.
2. Lee JK, Tang DH, Mollon L, Armstrong EP. Cost-effectiveness of biological agents used in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2013;27:949-60.
3. Tang DH, Armstrong EP, Lee JK. A cost-utility analysis of biologic treatments for moderate-to-severe Crohn’s disease. Pharmacotherapy 2012;32:515-26.
4. Tang DH, Malone DC. A network meta-analysis of efficacy of serotonin type 3 receptor antagnoists used in adults during first 24 hours for postoperative nausea and vomiting prophylaxis. Clinical Therapeutics 2012; 34:282-294.